SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-046071
Filing Date
2022-08-10
Accepted
2022-08-10 07:00:46
Documents
15
Period of Report
2022-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea164130-8k_biomxinc.htm   iXBRL 8-K 29746
2 PRESS RELEASE DATED AUGUST 10, 2022 ea164130ex99-1_biomxinc.htm EX-99.1 91096
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2799
  Complete submission text file 0001213900-22-046071.txt   365517

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phge-20220810.xsd EX-101.SCH 4204
5 XBRL DEFINITION FILE phge-20220810_def.xml EX-101.DEF 27449
6 XBRL LABEL FILE phge-20220810_lab.xml EX-101.LAB 38219
7 XBRL PRESENTATION FILE phge-20220810_pre.xml EX-101.PRE 26069
9 EXTRACTED XBRL INSTANCE DOCUMENT ea164130-8k_biomxinc_htm.xml XML 7448
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 221150361
SIC: 2836 Biological Products, (No Diagnostic Substances)